Trump Slaps 27% Tariff on India – Is This a Trade War Warning?

US President Donald Trump has announced a 27% “Discounted Reciprocal Tariff” on India, aiming to restructure trade imbalances. The sweeping tariff affects multiple sectors, including automobiles and IT, while pharmaceuticals remain exempt for now.

US President Donald Trump has announced a 27% “Discounted Reciprocal Tariff” on India, aiming to restructure trade imbalances. The sweeping tariff affects multiple sectors, including automobiles and IT, while pharmaceuticals remain exempt for now.

Stock Market Reacts to Tariff Impact

Following the announcement, Indian equity indices ended lower on Thursday.

Pharma Sector Sees Temporary Relief

The pharmaceutical industry, which contributes 14% of India’s exports to the US, was excluded from the tariff list.

Wider Economic Fallout from Tariffs

Brokerages have raised concerns over the broader economic impact on Indian exports.

IT Sector Faces Risks, But India Gains from China’s Higher Tariffs

While India faces higher tariffs, it could benefit from China’s steeper 34% duty effective April 9.

Trade Policy Experts Weigh In

According to Agneshwar Sen, Trade Policy Leader at EY India, the 27% tariff places India in the lower half of targeted nations, creating opportunities in sectors beyond engineering goods, electronics, gems, jewelry, textiles, and apparel.

“The tariffs could shift competitiveness in India’s favor, particularly in sectors where other regional exporters face more severe impacts,” Sen stated.

He emphasized that India must actively negotiate with the US while collaborating with FTA partners in Asia to restructure supply chains and capitalize on emerging trade opportunities.

Exit mobile version